UBS has downgraded its rating for SRF Ltd from BUY to SELL due to concerns over the company's recovery prospects.
SRF's share price has declined by over 7 percent in the past two weeks, and on October 16, the shares fell by 2.07 percent. The downgrade by UBS is notable considering the stock's recent performance, which has been volatile with a 52-week low of Rs 2081.25 and a high of Rs 2697.45.
UBS has lowered the target price from Rs 2700 to Rs 2100, highlighting the challenges SRF faces, including growth difficulties and weak demand in key sectors.
SRF's financial results for the quarter ending June 30, 2024, show a decline in sales and net profit compared to the previous year.
UBS has pointed to weak agro-chemical demand and potential market share gains by China as external factors affecting SRF's competitive position.
The stock has seen declines over various timeframes, raising concerns about its relative performance. However, SRF has shown significant long-term growth.
As SRF faces challenges in the chemical sector, strategic adjustments and innovation will be crucial for regaining investor confidence. The company's response to changing dynamics in the agro-chemical market and global competition will be closely monitored.